✦ LIBER ✦

PHARMACOGENOMICS:Genetic Variation as a Guide to Drug Development

✍ Scribed by Kleyn, P. W.

Book ID: 121160011
Publisher: American Association for the Advancement of Science
Year: 1998
Tongue: English
Weight: 773 KB
Volume: 281
Category: Article
ISSN: 0036-8075
DOI: 10.1126/science.281.5384.1820

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PS 4 Drug-induced arrhythmias as a windo

PS 4 Drug-induced arrhythmias as a window to pharmacogenomics

✍ Dan M. Rode 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 102 KB

The ‘precautionary principle’ as a guide

The ‘precautionary principle’ as a guide for future drug development

✍ S. Alban 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

A Comprehensive Guide to Toxicology in P

A Comprehensive Guide to Toxicology in Preclinical Drug Development || Immunotoxicology Assessment in Drug Development

✍ Farmer, John T. 📂 Article 📅 2013 🏛 Elsevier ⚖ 560 KB

Human genetics as a foundation for innov

Human genetics as a foundation for innovative drug development

✍ Kamb, Alexander; Harper, Sean; Stefansson, Kari 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 271 KB

Quantitative Analysis to Guide Orphan Dr

Quantitative Analysis to Guide Orphan Drug Development

✍ Lesko, L J 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB

A Comprehensive Guide to Toxicology in P

A Comprehensive Guide to Toxicology in Preclinical Drug Development || Carcinogenicity Evaluations using Genetically Engineered Animals

✍ McCormick, David L. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 167 KB

*A Comprehensive Guide to Toxicology in Preclinical Drug Development* is a resource for toxicologists in industry and regulatory settings, as well as directors working in contract resource organizations, who need a thorough understanding of the drug development process. Incorporating real-life case